Cited by 97Viral Infections and Immunology ResearchCardiac Fibrosis and RemodelingCardiomyopathy and Myosin Studies

Transcriptomic Biomarkers for the Accurate Diagnosis of Myocarditis

Open access
Heidecker, Bettina, Kittleson, Michelle M., Kasper, Edward K., Wittstein, Ilan S., Champion, Hunter C., Russell, Stuart D., Hruban, Ralph H., Rodriguez, E. Rene +2 more·2011·Circulation

Abstract

Background—: Lymphocytic myocarditis is a clinically important condition that is difficult to diagnose and distinguish. We hypothesized that the transcriptome obtained from an endomyocardial biopsy would yield clinically relevant and accurate molecular signatures. Methods and Results—: Microarray analysis was performed on samples from patients with histologically proven lymphocytic myocarditis (n=16) and idiopathic dilated cardiomyopathy (n=32) to develop accurate diagnostic transcriptome-based biomarkers using multiple classification algorithms. We identified 9878 differentially expressed genes in lymphocytic myocarditis versus idiopathic dilated cardiomyopathy (fold change >1.2; false discovery rate <5%) from which a transcriptome-based biomarker containing 62 genes was identified that distinguished myocarditis with 100% sensitivity (95% confidence interval, 46 to 100) and 100% specificity (95% confidence interval, 66 to 100) and was generalizable to a broad range of secondary cardiomyopathies associated with inflammation (n=27), ischemic cardiomyopathy (n=8), and the normal heart (n=11). Multiple classification algorithms and quantitative real-time reverse-transcription polymerase chain reaction analysis further reduced this subset to a highly robust molecular signature of 13 genes, which still performed with 100% accuracy. Conclusions—: Together, these findings demonstrate that transcriptomic biomarkers from a single endomyocardial biopsy can improve the clinical detection of patients with inflammatory diseases of the heart. This approach advances the clinical management and treatment of cardiac disorders with highly variable outcome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.110.002857

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-1β increases serum and cardiac IL-6 levels that are needed to drive Th17 responses, which promote fibrosis and progression to DCM and heart failure in patients with myocarditis and in animal models.

    “IL-1 β also increases serum and cardiac IL-6 levels that are needed to drive Th17 responses, which also promote fibrosis and progression to DCM and heart failure in patients with myocarditis and in animal models. 36,165,172-174”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [174]

    The Discussion (page not available) reports gene-expression differences between myocarditis and idiopathic dilated cardiomyopathy, but does not describe the claimed IL-1β–IL-6–Th17 pathway. Searches for IL-1β, IL-6, Th17, fibrosis, and progression to DCM or heart failure found no passage addressing that causal chain in patients or animal models. (LLM, conf=0.72)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. [4]Maekawa Y Ouzounian M Opavsky MA Liu PP Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. Circulation 2007 115 5 8 17200452
  2. [8]Cooper LT Baughman KL Feldman AM Frustaci A Jessup M Kuhl U Levine GN Narula J Starling RC Towbin J Virmani R The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 2007 116 2216 33 17959655
  3. [12]Mason JW O'Connell JB Herskowitz A Rose NR McManus BM Billingham ME Moon TE A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995 333 269 75 7596370
  4. [27]Baughman KL Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006 113 593 5 16449736
  5. [30]Hare JM Zipes DP Libby P Bonow R Braunwald E The dilated, restrictive and infiltrative cardiomyopathies. Braunwald's Heart Disease 2007 Elsevier
  6. [37]Margulies KB Matiwala S Cornejo C Olsen H Craven WA Bednarik D Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res 2005 96 592 9 15718504
  7. [38]Cooper LT Jr. Berry GJ Shabetai R Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 1997 336 1860 6 9197214
  8. [39]Cooper LT Jr. Shabetai R Immunosuppressive therapy for myocarditis. N Engl J Med 1995 333 1713 4 7477237

Cited by

Sorted by citations

Authors
Heidecker, B., Kittleson, M. M., Kasper, E. K., Wittstein, I. S., Champion, H. C., Russell, S. D., Hruban, R. H., Rodriguez, E. R., Baughman, K. L., & Hare, J. M.
Affiliations
  • Brigham and Women's Hospital (US)
  • From the University of Miami, Miller School of Medicine, Miami, FL (B.H., J.M.H.); Johns Hopkins Hospital, Baltimore, MD (E.K.K., I.S.W., S.D.R., R.H.H.); University of Pittsburgh, PA (H.C.C.); Cleveland Clinic Foundation, Cleveland, OH (E.R.R.); Department of Medicine, Division of Cardiology, University of California, Los Angeles (M.M.K.); and Brigham and Women's Hospital, Boston, MA (K.L.B.).
Venue
Circulation
Published
2011-03-22
Volume
123
Issue
11
Pages
1174-1184
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2167297686
Cited by
97
References
41
Citations by year
2026: 3 · 2025: 1 · 2024: 7 · 2023: 4 · 2022: 5 · 2021: 5 · 2020: 12 · 2019: 8 · 2017: 5 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 7 · 2012: 19
FWCI
7.70
Type
journal article
Language
en
Open access
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Johns Hopkins University
  • Myocarditis Foundation
  • National Institutes of Health
  • National Institute on Aging (R01AG025017)
  • National Heart, Lung, and Blood Institute (R01HL094849, R01HL084275, R01HL065455, U54HL081028)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords
lymphocytic myocarditis, transcriptomic biomarkers, endomyocardial biopsy, idiopathic dilated cardiomyopathy, differentially expressed genes, gene expression signatures, inflammatory cardiomyopathy, ischemic cardiomyopathy, cardiac inflammation
MeSH terms
Adult, Algorithms, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Cardiomyopathies, Myocarditis, Phenotype, Biomarkers, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review